Human CD255 (TWEAK) Recombinant Protein

Also known as: TNF-related weak inducer of apoptosis, APO3L

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 14-8916

Cat. No. Size
14-8916-62 5 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human CD255 (TWEAK) Recombinant Protein.

Description

Description: TWEAK, TNF-like weak inducer of apoptosis, is a member of the TNF family of proteins. TWEAK has the same sequence as APO-3 ligand. Based on homology with other members of the TNF ligand protein superfamily, the ligand is referred to also as TNF ligand superfamily member 12 [ TNFSF12 ]. TWEAK induces IL-8 synthesis in a number of cell lines. TWEAK induces cell death by apoptosis in the human adenocarcinoma cell line HT29 in the presence of IFN-γ. It's been reported that TWEAK contributes to macrophage homeostasis by mediating CD4 (+)T-cell killing of antigen-presenting macrophages. It's been reported that TWEAK plays a role in brain inflammation . Human astrocytes derived from different regions of the brain specifically bind TWEAK and are resistant to apoptosis mediated by TWEAK. TWEAK induces the production of large amounts of IL-8 and IL-6 in astrocytes and significantly increases the expression of ICAM-1. The TWEAK receptor has been cloned from a human umbilical vein endothelial cell library. The short cytoplasmic domain of this receptor binds TRAF-1 , TRAF-2 , and TRAF-3. Cross-linking of this receptor induces growth of human umbilical vein endothelial cells. The soluble receptor has been shown to inhibit endothelial cell migration in vitro and corneal angiogenesis in vivo.

Details
Reactivity Human
Purity Greater than 98%, as determined by SDS-PAGE
Molecular Mass Recombinant human TWEAK is a soluble 17.0 kDa polypeptide (154 amino acid residues) comprising the TNF homologous region of TWEAK and is generated by proteolytic processing of the full length membrane anchored TWEAK protein.
Reported Applications ELISA, Cytokine Bioassays
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
References

References: Chicheportiche, Y. et al. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272: 32401-32410
Kaplan. M.J. et al. 2000. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. J. Immunol. 164: 2897-2904.
www.copewithcytokines.de